How I investigate for bleeding disorders

被引:31
作者
Hayward, C. P. M. [1 ,2 ,3 ]
机构
[1] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Hamilton Reg Lab Med Program, Hamilton, ON, Canada
基金
加拿大健康研究院;
关键词
coagulation; hemophilia; hemostasis; platelet function; von Willebrand disease; VON-WILLEBRAND-DISEASE; TRANSMISSION PLATELET AGGREGOMETRY; ADENOSINE-TRIPHOSPHATE RELEASE; DENSE-GRANULE DEFICIENCY; DIAGNOSIS; VARIABILITY; HEMOSTASIS; GUIDELINES;
D O I
10.1111/ijlh.12822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Laboratory investigations for bleeding disorders are warranted when an individual has a personal and/or family history of bleeding, and/or laboratory findings that suggest the possibility of an inherited or acquired bleeding disorder. Methods: This review summarizes author's experience with ordering and reporting on diagnostic investigations for common and rare bleeding disorders, with consideration of recent articles on diagnosing bleeding disorders. An updated strategy is presented for investigating common and rare, congenital and acquired bleeding disorders. Results: An investigation of a suspected bleeding disorder requires a practical strategy that considers the clinical problem to be investigated, the pretest probability of true-positive and false-positive findings, the investigations can be performed locally or in a reference laboratory and limit the number of blood samples required to establish a diagnosis. It is often advantageous to simultaneously test for von Willebrand disease and platelet function disorders, and for coagulation defects, including fibrinogen disorders. An investigation for rarer bleeding disorders, including those affecting factor XIII, alpha(2) antiplasmin, and plasminogen activator inhibitor-1, is appropriate when faced with a severe congenital or acquired bleeding problem that cannot be explained by the initial diagnostic investigations. Conclusion: An organized strategy for investigating bleeding disorders that consider important issues, confirms abnormal findings, encourages proper interpretation of the results, and provides a helpful framework for assessing both common and rare causes of bleeding.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 37 条
  • [1] [Anonymous], 2017, GENEREVIEWS
  • [2] Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation
    Badin, M. S.
    Iyer, J. K.
    Chong, M.
    Graf, L.
    Rivard, G. E.
    Waye, J. . S.
    Paterson, A. D.
    Pare, G.
    Hayward, C. P. M.
    [J]. HAEMOPHILIA, 2017, 23 (03) : E204 - E213
  • [3] Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder
    Badin, M. S.
    Graf, L.
    Iyer, J. K.
    Moffat, K. A.
    Seecharan, J. L.
    Hayward, C. P. M.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (06) : 648 - 657
  • [4] Genomic landscape of megakaryopoiesis and platelet function defects
    Bianchi, Elisa
    Norfo, Ruggiero
    Pennucci, Valentina
    Zini, Roberta
    Manfredini, Rossella
    [J]. BLOOD, 2016, 127 (10) : 1249 - 1259
  • [5] Controversies in the diagnosis of Type 1 von Willebrand disease
    Bowman, M. L.
    James, P. D.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 61 - 68
  • [6] Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency
    Brunet, J. G.
    Iyer, J. K.
    Badin, M. S.
    Graf, L.
    Moffat, K. A.
    Timleck, M.
    Spitzer, E.
    Hayward, C. P. M.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (04) : 400 - 407
  • [7] A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?
    Castilloux, Jean Francois
    Moffat, Karen A.
    Liu, Yang
    Seecharan, Jodi
    Pai, Menaka
    Hayward, Catherine P. M.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) : 675 - 682
  • [8] Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
    Cattaneo, M.
    Cerletti, C.
    Harrison, P.
    Hayward, C. P. M.
    Kenny, D.
    Nugent, D.
    Nurden, P.
    Rao, A. K.
    Schmaier, A. H.
    Watson, S. P.
    Lussana, F.
    Pugliano, M. T.
    Michelson, A. D.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (06) : 1183 - 1189
  • [9] Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
    Dahlback, Bjorn
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 4 - 11
  • [10] Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis
    Diamandis, M
    Adam, F
    Kahr, WHA
    Wang, P
    Chorneyko, KA
    Arsenault, AL
    Rivard, GE
    Hayward, CPM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) : 1086 - 1094